By Christina Vogt, via Consultant360.com. The American Society of Clinical Oncology has recently updated its breast cancer clinical guideline, adding a genomic test called MammaPrint as a new way to guide treatment decisions in certain breast cancer patients. Read More

Photo Credit: Consultant360